Investigators concluded that the spiked samples from SeraCare were a robust tool for inter-lab comparisons and discussed some areas of discordance seen in the study.
A bill passed by a US House of Representatives appropriations subcommittee would give scientific agencies including the National Science Foundation boosts in funding.
The methods address challenges like recall and precision, comparing different representations of variant calls, and stratifying performance by variant type and genome context.
Researchers may experience the effects of the government shutdown for a while, the Los Angeles Times reports.
The technique provides the scientific community with a higher-resolution methodology to determine if a mouse cell line has been correctly identified in research.
The public-private consortium, led by the National Institute of Standards and Technology, recently released four new reference materials.
The material has a similar benefit to graphene, in that it is one-atom thin, but has the benefit that DNA does not stick to it as it translocates through the pore.
The firm will provide DNA from at least 50 mouse cell lines for use in a PCR-based validation assay.
The partners have signed a three-year R&D agreement under which SeraCare will provide its ctDNA reference materials to NIST for comparison between labs.
The researchers found that many clinically relevant genes fall in regions of the genome that cannot be confidently sequenced and analyzed.
23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.
By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.
NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.
In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.